Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials

FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti

July 12, 2018

Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment

July 12, 2018

Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development

February 1, 2018

Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments

June 29, 2018

Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference

Jane Larkindale, Executive Director of D-RSC, attended the Parent Project Muscular Dystrophy (PPMD) 2018 Annual Conference in...

June 24, 2018

Completing Patient-Reported Outcome Measures Electronically: A Review of the Literature on Subject Burden in Clinical Trials

January 6, 2018

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study

January 6, 2018

Mycobacterial biomaterials and resources for researchers

January 6, 2018

Informing the tolerability of cancer treatments using patient-reported outcome (PRO) measures: summary of an FDA and Critical Path Institute workshop

January 6, 2018

Selection of and evidentiary considerations for wearable devices and their measurements for use in regulatory decision making: recommendations from the ePRO Consortium

Previous8081 82...131 Next